EyRIS

EyRIS is a healthcare technology company based in Singapore, founded in 2018. The company specializes in developing AI Deep Learning Systems for medical image analysis, particularly in ophthalmology. Its flagship product, SELENA+, automates the analysis of retinal images to detect various eye diseases, including Diabetic Retinopathy, Glaucoma Suspect, and Age-related Macular Degeneration. SELENA+ utilizes Convolutional Neural Networks to accurately recognize disease characteristics, having been trained on nearly 500,000 retinal images. In addition to SELENA+, EyRIS offers tele-ophthalmology services that facilitate remote eye screening and diagnosis. The company primarily serves healthcare providers and institutions involved in eye care, supporting early detection and screening programs, especially for diabetic eye diseases. EyRIS aims to enhance diagnostic accuracy and healthcare productivity while lowering costs, contributing to public health initiatives in Singapore's National Artificial Intelligence Strategy. The founding team comprises experts from various fields, including ophthalmology, computer science, and health technology.

• Employees 15
• Founded 2018